JP2023525778A5 - - Google Patents
Info
- Publication number
- JP2023525778A5 JP2023525778A5 JP2022568460A JP2022568460A JP2023525778A5 JP 2023525778 A5 JP2023525778 A5 JP 2023525778A5 JP 2022568460 A JP2022568460 A JP 2022568460A JP 2022568460 A JP2022568460 A JP 2022568460A JP 2023525778 A5 JP2023525778 A5 JP 2023525778A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequences
- cdr2
- cdr3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020103942965 | 2020-05-11 | ||
| CN202010394296.5A CN113637073B (zh) | 2020-05-11 | 2020-05-11 | Bcma抗体及其制备和应用 |
| PCT/US2021/031299 WO2021231213A1 (en) | 2020-05-11 | 2021-05-07 | Anti-bcma antibodies and chimeric antigen receptors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023525778A JP2023525778A (ja) | 2023-06-19 |
| JP2023525778A5 true JP2023525778A5 (cg-RX-API-DMAC7.html) | 2024-02-21 |
| JP7883955B2 JP7883955B2 (ja) | 2026-07-02 |
Family
ID=78415523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568460A Active JP7883955B2 (ja) | 2020-05-11 | 2021-05-07 | 抗bcma抗体およびキメラ抗原受容体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12673071B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4149967A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7883955B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113637073B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021231213A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116333134A (zh) * | 2021-12-22 | 2023-06-27 | 上海君实生物医药科技股份有限公司 | 抗bcma抗体及其用途 |
| CN117003871A (zh) * | 2022-04-28 | 2023-11-07 | 北京天广实生物技术股份有限公司 | 结合bcma和cd3的抗体及其用途 |
| CN116063521B (zh) * | 2022-10-31 | 2024-05-14 | 北京奇迈永华生物科技有限公司 | 靶向bcma的抗体及其所构成的嵌合抗原受体 |
| WO2025171388A1 (en) | 2024-02-09 | 2025-08-14 | Dispatch Biotherapeutics, Inc. | Engineered cancer antigens with modified domains and related methods and uses |
| WO2025171383A2 (en) | 2024-02-09 | 2025-08-14 | Dispatch Biotherapeutics, Inc. | Engineered cancer antigens and related methods and uses |
| WO2026006767A1 (en) | 2024-06-28 | 2026-01-02 | Dispatch Biotherapeutics, Inc. | Tethered il-9/il-9r and related engineered cells and methods |
| CN119119274B (zh) * | 2024-09-26 | 2026-08-11 | 北京昌盛鸿途生物科技有限公司 | 一种靶向bcma的cart细胞及其应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
| US5350674A (en) | 1992-09-04 | 1994-09-27 | Becton, Dickinson And Company | Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof |
| EP1235842A4 (en) | 1999-10-15 | 2003-04-23 | Univ Massachusetts | Rna interference pathway genes as tools for targeted genetic interference |
| US6326193B1 (en) | 1999-11-05 | 2001-12-04 | Cambria Biosciences, Llc | Insect control agent |
| WO2001096584A2 (en) | 2000-06-12 | 2001-12-20 | Akkadix Corporation | Materials and methods for the control of nematodes |
| TWI548418B (zh) | 2007-12-05 | 2016-09-11 | 中外製藥股份有限公司 | Anti-NR10 / IL-31RA antibody and its use |
| US8840890B2 (en) * | 2008-11-12 | 2014-09-23 | University Of Maryland, Baltimore | Rapid expression cloning of human monoclonal antibodies from memory B cells |
| CA2934965A1 (en) | 2014-01-31 | 2016-03-17 | Boehringer Ingelheim International Gmbh | Novel anti-baff antibodies |
| EP3131927B8 (en) | 2014-04-14 | 2020-12-23 | Cellectis | Bcma (cd269) specific chimeric antigen receptors for cancer immunotherapy |
| BR112016024546A2 (pt) | 2014-04-30 | 2018-01-23 | Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft | anticorpo ou fragmento de anticorpo, anticorpo ou fragmento de anticorpo isolado, conjugado de anticorpo-fármaco, molécula de ácido nucleico, célula hospedeira, e, composição farmacêutica |
| JP6815329B2 (ja) * | 2015-03-23 | 2021-01-20 | バイエル ファーマ アクチエンゲゼルシャフト | 抗ceacam6抗体およびその使用 |
| CN108026172B (zh) | 2015-06-26 | 2022-04-29 | 赛诺菲生物技术公司 | 单克隆抗il-1racp抗体 |
| TWI811023B (zh) * | 2015-08-17 | 2023-08-01 | 美商健生生物科技公司 | 抗bcma抗體,結合bcma及cd3之雙特異性抗原結合分子及其用途 |
| CN105777911B (zh) * | 2016-04-12 | 2019-07-02 | 上海优卡迪生物医药科技有限公司 | 抗bcma嵌合抗原受体、编码基因、重组表达载体及其构建方法和应用 |
| WO2017181098A2 (en) | 2016-04-15 | 2017-10-19 | Visterra, Inc. | Antibody molecules to zika virus and uses thereof |
| EP3448874A4 (en) * | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| UA126813C2 (uk) | 2017-08-01 | 2023-02-08 | Медімм'Юн, Ллк | Моноклональний кон’югат антитіло-лікарський засіб до bcma |
| CN116836297A (zh) | 2018-04-12 | 2023-10-03 | 上海赛比曼生物科技有限公司 | 靶向bcma的嵌合抗原受体及其制法和应用 |
-
2020
- 2020-05-11 CN CN202010394296.5A patent/CN113637073B/zh active Active
-
2021
- 2021-05-07 US US17/924,410 patent/US12673071B2/en active Active
- 2021-05-07 EP EP21804265.3A patent/EP4149967A4/en active Pending
- 2021-05-07 JP JP2022568460A patent/JP7883955B2/ja active Active
- 2021-05-07 WO PCT/US2021/031299 patent/WO2021231213A1/en not_active Ceased